RDY 572 (Fexofenadine and Pseudoephedrine Extended Release 180 mg / 240 mg)

Pill imprint RDY 572 has been identified as Fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release 180 mg / 240 mg.

Fexofenadine/pseudoephedrine is used in the treatment of allergic rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Fexofenadine/pseudoephedrine 180 mg / 240 mg is not a controlled substance under the Controlled Substance Act (CSA).

Fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release

Imprint:

RDY 572

Strength:

180 mg / 240 mg

Color:

White

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

Upper respiratory combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Dr. Reddy’s Laboratories Limited

National Drug Code (NDC):

55111-0572

Inactive Ingredients:

acetyltributyl citrate
croscarmellose sodium
silicon dioxide colloidal
ethylcelluloses
copovidone
hypromelloses
microcrystalline cellulose
polyethylene glycol
sodium stearyl fumarate
magnesium silicate
titanium dioxide
hydrogenated cottonseed oil

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.